at MarketWatch.com (Dec 31, 2014)
More on Rosetta Stone's Q2: No explanation is given for the poor results. However, the company notes international consumer sales fell 33% Y/Y to $8.1M, worse than Q1's 14% drop, and U.S. consumer swung from a 52% Q1 increase to a 4% decline. Institutional sales fell 2%, nearly even with Q1. Rosetta is expanding its 2012 adjusted EBITDA guidance range to the downside, but is leaving its revenue guidance unchanged. The Street appears skeptical. RST -23.8% AH. (PR)
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at MarketWatch.com (Dec 30, 2014)
at Zacks.com (Dec 10, 2014)
at CNBC.com (Apr 5, 2013)
at Fox Business (Apr 2, 2013)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs